Peer-reviewed veterinary case report
Using dexmedetomidine during pulmonic balloon valvuloplasty in dogs
By Martin-Flores, Manuel et al.·Published in The Veterinary record·2021·Department of Clinical Sciences, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: The use of dexmedetomidine during pulmonic balloon valvuloplasty in dogs.
- Species:
- dog
Plain-English summary
A group of dogs undergoing a heart procedure called pulmonic balloon valvuloplasty (PBV) received a sedative called dexmedetomidine during anesthesia. This treatment helped reduce the need for additional medications to manage blood pressure and heart rate during the surgery. While both groups of dogs experienced some drop in heart rate, those given dexmedetomidine needed less help to stabilize their condition. Overall, using dexmedetomidine during this procedure appears to be beneficial for dogs undergoing PBV.
People also search for: dog heart surgery anesthesia · dexmedetomidine for dogs · pulmonic balloon valvuloplasty in dogs
Abstract
BACKGROUND: Information regarding the anaesthetic management for pulmonic balloon valvuloplasty (PBV) in dogs is scarce. We present data from dogs receiving dexmedetomidine combined with inhalational anaesthesia during PBV. METHODS: Anaesthetic records from dogs receiving dexmedetomidine (n = 11) and a control group (n = 29) anaesthetised for PBV between 2012 and 2020 were analysed. Intraoperative variables potentially affected by dexmedetomidine administration were compared between groups. RESULTS: Demographic characteristic and anaesthetic agents administered were similar between groups. The incidence of hypotension (mean arterial pressure (MAP) < 60 mm Hg) was 25% for dexmedetomidine and 29% for control (p = 0.8); however, dexmedetomidine group received vasopressors for a shorter time (p = 0.02). The incidence of bradycardia was 100% and 96% for dexmedetomidine and control (p = 0.5), but antimuscarinic agents were administered more frequently to the latter (p = 0.014). CONCLUSION: Dexmedetomidine may be a useful adjuvant to general anaesthesia during PBV in dogs and reduced the use of vasopressors and antimuscarinics.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/33969500/